Cartilage discovery offers arthritis hope

Scientists have revealed the intricate structure of cartilage in what they hope will provide clues to how the crippling joint disease osteoarthritis might one day be treated.

The disease, which affects more than five million people in the UK, is caused by the wear and tear of the smooth, hard cartilage tissue that covers the ends of bones allowing them to glide over one another at the joint.

Scientists have long known that cartilage gets its strength from interlocking millimetre-long collagen fibres that work in a similar way to the load-bearing steel rods in reinforced concrete.

But the precise structure of these fibres or ‘fibrils' has remained a mystery for more than 40 years, so hindering any progress towards the development of potential therapies.

Now, a team from The University of Manchester has used sophisticated electron microscope techniques to uncover the molecular structure of the thinner of the two types of collagen fibrils.

Professor Karl Kadler, who led the research in the Faculty of Life Sciences, said: "The ability of cartilage to withstand cycles of compression and relaxation is directly attributable to the collagen fibrils.

"Osteoarthritis occurs when the fibrils are disrupted or lost - just like concrete without the steel, the cartilage becomes mechanically weak and susceptible to wear and tear.

"Eventually, the cartilage breaks down altogether and sufferers experience severe pain as the two ends of the bones rub against each other."

The team's findings - published in the journal Proceedings of the National Academy of Sciences - also explain why mutations in cartilage collagen genes cause osteoarthritis.

"Without a detailed understanding of the structure of these fibrils, a treatment that prevents them deteriorating would always prove elusive," said Professor Kadler.

"This research, while just a beginning, at least establishes some basic scientific facts that could prove useful in future studies on osteoarthritis and related conditions."

The next stage of the team's work will be to determine the structure of the thicker fibrils and examine how collagen cells manage to produce these relatively large fibrous structures which are 1,000 times their own size.

Once scientists understand how the fibrils form and develop in healthy cartilage, they can then investigate what happens when things go wrong in diseases like osteoarthritis.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The University of Manchester. (2019, June 19). Cartilage discovery offers arthritis hope. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/2007/01/10/21371.aspx.

  • MLA

    The University of Manchester. "Cartilage discovery offers arthritis hope". News-Medical. 24 April 2024. <https://www.news-medical.net/news/2007/01/10/21371.aspx>.

  • Chicago

    The University of Manchester. "Cartilage discovery offers arthritis hope". News-Medical. https://www.news-medical.net/news/2007/01/10/21371.aspx. (accessed April 24, 2024).

  • Harvard

    The University of Manchester. 2019. Cartilage discovery offers arthritis hope. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/2007/01/10/21371.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibody drug conjugate could hold promise in improving treatment for childhood ALL